chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoxia, Imaging procedure abnormal, Lung opacity, Malaise
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 04/13/21, who admitted with COVID detected PCR and COVID symptoms.  Provider D/C note below:  "75  female with past medical history significant for recent hospitalization for diarrhea found to have C. Difficile colitis and Enteropathogenic E. Coli status post 14 day course of fidaxomicin completed on 11/25 after failing to improve on oral Vancomycin.  Patient presents with several day history generalized weakness, fatigue, LLQ pain and recurrent diarrhea. She also complained of headaches.  She is vaccinated for COVID 19 but is found to be positive.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  *Fever with LLQ abdominal pain in setting of recent treatment for C. Difficile colitis and Enteropathogenic E. Coli with known diverticulosis and history of diverticulitis - no evidence of diverticulitis on CT of Abdomen - GI stool PCR not sent because no loose stools throughout admission, fever likely due to COVID 19, chronic abdominal pain consistent with history of IBS, Dicyclomine for abdominal cramping, using Norco as at home, could consider adding Nortriptyline 25 mg BID as an outpatient if patient continues to have symptoms, recommend referral to GI for possible colonoscopy   *Acute respiratory failure in setting of COVID 19 pneumonia with chest imaging showing multifocal bibasilar opacities, CRP 23.7, D-dimer 1,390, ABG with central hypoxia with paO2 of 55 on room air, received Decadron 6 mg daily, Heparin subq for DVT prophylaxis, did not give Remdesivir with advanced kidney disease, patient weaned to 2 liters by NC by time of discharge (she typically wears 2 liters a night when sleeping at home).   *Acute on chronic kidney injury stage IV - slowly resolved after 1 liter NS fluid bolus and some limited maintenance IV Fluids, holding home blood pressure medications including ARB, continued home sodium bicarbonate tablets   *Peripheral vascular disease status post bilateral SFA stents in 2015, L anterior tibial angioplasty 7/2019, on DAPT and Statin for that   *History of lacunar strokes - Aspirin, Statin   *COPD - continue home Symbicort, Albuterol prn   *Restless leg syndrome - Ropinirole   *GERD - PPI"
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: PO2 decreased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 04/13/21, who admitted with COVID detected PCR and COVID symptoms.  Provider D/C note below:  "75  female with past medical history significant for recent hospitalization for diarrhea found to have C. Difficile colitis and Enteropathogenic E. Coli status post 14 day course of fidaxomicin completed on 11/25 after failing to improve on oral Vancomycin.  Patient presents with several day history generalized weakness, fatigue, LLQ pain and recurrent diarrhea. She also complained of headaches.  She is vaccinated for COVID 19 but is found to be positive.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  *Fever with LLQ abdominal pain in setting of recent treatment for C. Difficile colitis and Enteropathogenic E. Coli with known diverticulosis and history of diverticulitis - no evidence of diverticulitis on CT of Abdomen - GI stool PCR not sent because no loose stools throughout admission, fever likely due to COVID 19, chronic abdominal pain consistent with history of IBS, Dicyclomine for abdominal cramping, using Norco as at home, could consider adding Nortriptyline 25 mg BID as an outpatient if patient continues to have symptoms, recommend referral to GI for possible colonoscopy   *Acute respiratory failure in setting of COVID 19 pneumonia with chest imaging showing multifocal bibasilar opacities, CRP 23.7, D-dimer 1,390, ABG with central hypoxia with paO2 of 55 on room air, received Decadron 6 mg daily, Heparin subq for DVT prophylaxis, did not give Remdesivir with advanced kidney disease, patient weaned to 2 liters by NC by time of discharge (she typically wears 2 liters a night when sleeping at home).   *Acute on chronic kidney injury stage IV - slowly resolved after 1 liter NS fluid bolus and some limited maintenance IV Fluids, holding home blood pressure medications including ARB, continued home sodium bicarbonate tablets   *Peripheral vascular disease status post bilateral SFA stents in 2015, L anterior tibial angioplasty 7/2019, on DAPT and Statin for that   *History of lacunar strokes - Aspirin, Statin   *COPD - continue home Symbicort, Albuterol prn   *Restless leg syndrome - Ropinirole   *GERD - PPI"
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Deep vein thrombosis, Dyspnoea
Clinical narrative: Patient admitted with sternal chest pain and SOB. Previously diagnosed with DVT on 4/5/2022.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Hyperacusis, Loss of consciousness
Clinical narrative: -nausea -dizziness -feeling off balance -floating feeling when I go for walks -black out when I sit up too quickly -heart palpitations at night -eyesight is odd and I feel as if I'm cross-eyed at times -ears are extra sensitive to loud noises -fatigue -overall quality of life has been severely affected  All of these symptoms were constant for the first 6 weeks after receiving the third shot. They are not as bad now, but they still come and go. I have not had any treatment. Also, if I attempt to drink alcohol it tends to worsen my symptoms.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Palpitations, Quality of life decreased, Visual impairment
Clinical narrative: -nausea -dizziness -feeling off balance -floating feeling when I go for walks -black out when I sit up too quickly -heart palpitations at night -eyesight is odd and I feel as if I'm cross-eyed at times -ears are extra sensitive to loud noises -fatigue -overall quality of life has been severely affected  All of these symptoms were constant for the first 6 weeks after receiving the third shot. They are not as bad now, but they still come and go. I have not had any treatment. Also, if I attempt to drink alcohol it tends to worsen my symptoms.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Influenza like illness, Pain, Pyrexia
Clinical narrative: I experienced flu like symptoms of fever, body aches, fatigue, weakness which began 4/6/21 at 9pm and lasted around 24 hours.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Dizziness, Electrocardiogram normal, Vertigo
Clinical narrative: Vertigo Dizziness  Meclizine- did not reduce symptoms Valium Currently have a follow up appointment with my primary doctor.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Documented that 0.2 mg were administered and should have been 0.3 ml administered.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood glucose increased, Blood sodium decreased
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Breath sounds abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram QT prolonged, Electrocardiogram abnormal, Fall, Full blood count normal, Hypersensitivity
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Insulin therapy, Lung opacity, Metabolic function test, Mobility decreased
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Plantar fasciitis, Pyrexia, Rash, Rash erythematous, Rash macular
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, SARS-CoV-2 test positive, Sinus tachycardia, Skin lesion, Speech disorder
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Wheelchair user, Wheezing
Clinical narrative: Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Ultrasound scan normal
Clinical narrative: On April 15, 2021; approximately in the morning I noticed I had a raised lump on my neck, between my neck collar bone on the left hand side. I went to the doctor May 28, 2021 and they ordered an ultrasound. Nothing was found.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Inappropriate schedule of product administration, Lymphadenopathy, Vertigo, Vomiting
Clinical narrative: 1 hour after vaccine, began to experience vertigo and lymph node swelling in chest and armpits.  3 hours after, vertigo became extreme with spinning and vomiting.  Lymph nodes increased in swelling and pain by left clavicle.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness postural, Hyperhidrosis, Loss of consciousness, Mobility decreased
Clinical narrative: So I basically I had soreness throughout the night after I got the vaccine, at 5:00 in the morning I woke up needing to use the restroom, and when I sat up I got very dizzy so I sat for a little bit  then when I went to get up I passed out completely,  I did not hit my had head on the floor, as I came to I was completely sweaty and dry heaving, and I needed to use the restroom. So for the rest of the entire day, I was unable to sit in a chair without passing out, and I had a telehealth visit with the doctor at about 2:00 in the afternoon, and I was able to sit up a little bit, but I was still in the bed, the symptoms were slightly trying to wear off at that time.  The physician assistant said I was having a vaso-vagal reaction to the vaccine.  They wanted me to go to the hospital, and I declined to go, I did not want to be in a hospital room fainting as the symptoms were slightly fading, I did not want to be alone at that point. I continued to have some weakness for about 3-4 weeks after the injection.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Presyncope, Retching
Clinical narrative: So I basically I had soreness throughout the night after I got the vaccine, at 5:00 in the morning I woke up needing to use the restroom, and when I sat up I got very dizzy so I sat for a little bit  then when I went to get up I passed out completely,  I did not hit my had head on the floor, as I came to I was completely sweaty and dry heaving, and I needed to use the restroom. So for the rest of the entire day, I was unable to sit in a chair without passing out, and I had a telehealth visit with the doctor at about 2:00 in the afternoon, and I was able to sit up a little bit, but I was still in the bed, the symptoms were slightly trying to wear off at that time.  The physician assistant said I was having a vaso-vagal reaction to the vaccine.  They wanted me to go to the hospital, and I declined to go, I did not want to be in a hospital room fainting as the symptoms were slightly fading, I did not want to be alone at that point. I continued to have some weakness for about 3-4 weeks after the injection.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Asthenia, Dizziness, Dyspepsia, Mental impairment
Clinical narrative: weakness, stomach digestive trouble for over 1 week, soreness, dizziness, restlessness, trouble tracking/thinking
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Restlessness
Clinical narrative: weakness, stomach digestive trouble for over 1 week, soreness, dizziness, restlessness, trouble tracking/thinking
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Computerised tomogram normal, Laboratory test normal, Tinnitus
Clinical narrative: ~ 1 month after booster dose I began having tinnitus ( ringing) and pulsatile tinnitus both ears.  Never had previously, had full ENT workup including CT, CTA, carotid studies.  All of which were negative.  Physical exam , lab work  , vitals all normal
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Blood pressure measurement, Blood test, Computerised tomogram, Investigation
Clinical narrative: ~ 1 month after booster dose I began having tinnitus ( ringing) and pulsatile tinnitus both ears.  Never had previously, had full ENT workup including CT, CTA, carotid studies.  All of which were negative.  Physical exam , lab work  , vitals all normal
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Ultrasound scan
Clinical narrative: ~ 1 month after booster dose I began having tinnitus ( ringing) and pulsatile tinnitus both ears.  Never had previously, had full ENT workup including CT, CTA, carotid studies.  All of which were negative.  Physical exam , lab work  , vitals all normal
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Postmenopausal haemorrhage
Clinical narrative: Approximately 2 months after my vaccination I had the following symptoms: I started having my menstrual cycle again after not having it for 3 years. No other symptoms experienced, and when I called my doctor she said that she has been seeing a lot of patients who got vaccinated that were experiencing the same thing. Up until this day (04/11/2022) I still have my regular menstrual cycle despite having birth control.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Failure to thrive, Hypoxia, Loss of personal independence in daily activities, SARS-CoV-2 test positive
Clinical narrative: Patient with 2 Pfizer vaccinations, last dose 02/04/21, who admitted with hypoxia and positive COVID test who subsequently had failure to thrive.  Respiratory status improved, however, had complex care giver needs upon discharge with pending guardianship issues and had prolonged hospital stay.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test abnormal, Blood thyroid stimulating hormone normal, C-reactive protein, Diarrhoea, Full blood count normal
Clinical narrative: Diarrhea, started in October, has persisted and gotten much worse
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Red blood cell sedimentation rate normal, Stool analysis normal
Clinical narrative: Diarrhea, started in October, has persisted and gotten much worse
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Gait disturbance, Inflammation, Inflammatory marker increased, Peripheral swelling
Clinical narrative: My left foot develop severe swelling on top of the foot. It was redness and hardness. It was hard to put a shoe on and to walk. These is still ongoing. I went to my doctor about this. They did blood work, showed high level of inflammation in my bloodstream. There is no injury for this to happen. I am on medicine right now to get it under control.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Skin induration
Clinical narrative: My left foot develop severe swelling on top of the foot. It was redness and hardness. It was hard to put a shoe on and to walk. These is still ongoing. I went to my doctor about this. They did blood work, showed high level of inflammation in my bloodstream. There is no injury for this to happen. I am on medicine right now to get it under control.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Cardiac failure
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 05/05/21, who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission:  62 year old male with past medical history significant for nicotine dependence, asthma, obstructive sleep apnea, chronic heart failure with reduced EF in setting of nonischemic dilated cardiomyopathy, status post AICD, left renal infarct due to thromboembolism on chronic anticoagulation, failed right total right knee replacement with removal of prosthesis on suppressive antibiotics, chronic kidney disease stage 2, chronic pain on chronic opiates, anxiety on chronic benzodiazepines and depression presented with acute respiratory failure with hypoxia and viral sepsis in setting of COVID 19 pneumonia.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient required up to 100% FiO2 and 15 liter Venturi mask alternating with non-rebreather. He was started on Decadron while continued on home Eliquis.  Remdesivir was not used in setting of worsening renal failure.   With persistent hypoxia, steroids were escalated to Methylprednisolone 1 mg/kg daily in two divided doses.  Patient's oxygen requirements slowly decreased and oxygen was weaned to 4 liters by nasal cannula by time of discharge.  He was discharged on a prednisone taper.    On admission, patient had worsening renal failure with hyperkalemia.  Patient received a small IV Fluid bolus and home Entresto and loop diuretics were held.  Patient was started on Lokelma three times daily.  Eventually renal function returned towards baseline and patient was started on IV Lasix to promote negative fluid balance and then was transitioned back to his home Torsemide prior to discharge.  Patient was normotensive at time of discharge off home Entresto.    Patient was also started on Tamsulosin in the setting of urinary retention with symptoms resolving prior to discharge.    Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of respiratory failure in setting of continued recovery from COVID 19 pneumonia with PCP; follow-up smoking cessation with PCP; consider referral to pulmonology if oxygen requirement persists; follow-up with cardiology regarding chronic heart failure with reduced ejection fraction (Entresto held due to worsening kidney failure and hyperkalemia); follow-up failed right knee prosthesis on suppressive antibiotics with Orthopaedics; follow-up right hand numbness if persists with neurology; follow-up other issues with PCP"
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Ex-tobacco user, Hyperkalaemia, Hypoaesthesia, Hypoxia
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 05/05/21, who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission:  62 year old male with past medical history significant for nicotine dependence, asthma, obstructive sleep apnea, chronic heart failure with reduced EF in setting of nonischemic dilated cardiomyopathy, status post AICD, left renal infarct due to thromboembolism on chronic anticoagulation, failed right total right knee replacement with removal of prosthesis on suppressive antibiotics, chronic kidney disease stage 2, chronic pain on chronic opiates, anxiety on chronic benzodiazepines and depression presented with acute respiratory failure with hypoxia and viral sepsis in setting of COVID 19 pneumonia.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient required up to 100% FiO2 and 15 liter Venturi mask alternating with non-rebreather. He was started on Decadron while continued on home Eliquis.  Remdesivir was not used in setting of worsening renal failure.   With persistent hypoxia, steroids were escalated to Methylprednisolone 1 mg/kg daily in two divided doses.  Patient's oxygen requirements slowly decreased and oxygen was weaned to 4 liters by nasal cannula by time of discharge.  He was discharged on a prednisone taper.    On admission, patient had worsening renal failure with hyperkalemia.  Patient received a small IV Fluid bolus and home Entresto and loop diuretics were held.  Patient was started on Lokelma three times daily.  Eventually renal function returned towards baseline and patient was started on IV Lasix to promote negative fluid balance and then was transitioned back to his home Torsemide prior to discharge.  Patient was normotensive at time of discharge off home Entresto.    Patient was also started on Tamsulosin in the setting of urinary retention with symptoms resolving prior to discharge.    Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of respiratory failure in setting of continued recovery from COVID 19 pneumonia with PCP; follow-up smoking cessation with PCP; consider referral to pulmonology if oxygen requirement persists; follow-up with cardiology regarding chronic heart failure with reduced ejection fraction (Entresto held due to worsening kidney failure and hyperkalemia); follow-up failed right knee prosthesis on suppressive antibiotics with Orthopaedics; follow-up right hand numbness if persists with neurology; follow-up other issues with PCP"
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal failure, Renal impairment, Respiratory failure, SARS-CoV-2 test positive, Urinary retention
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 05/05/21, who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission:  62 year old male with past medical history significant for nicotine dependence, asthma, obstructive sleep apnea, chronic heart failure with reduced EF in setting of nonischemic dilated cardiomyopathy, status post AICD, left renal infarct due to thromboembolism on chronic anticoagulation, failed right total right knee replacement with removal of prosthesis on suppressive antibiotics, chronic kidney disease stage 2, chronic pain on chronic opiates, anxiety on chronic benzodiazepines and depression presented with acute respiratory failure with hypoxia and viral sepsis in setting of COVID 19 pneumonia.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient required up to 100% FiO2 and 15 liter Venturi mask alternating with non-rebreather. He was started on Decadron while continued on home Eliquis.  Remdesivir was not used in setting of worsening renal failure.   With persistent hypoxia, steroids were escalated to Methylprednisolone 1 mg/kg daily in two divided doses.  Patient's oxygen requirements slowly decreased and oxygen was weaned to 4 liters by nasal cannula by time of discharge.  He was discharged on a prednisone taper.    On admission, patient had worsening renal failure with hyperkalemia.  Patient received a small IV Fluid bolus and home Entresto and loop diuretics were held.  Patient was started on Lokelma three times daily.  Eventually renal function returned towards baseline and patient was started on IV Lasix to promote negative fluid balance and then was transitioned back to his home Torsemide prior to discharge.  Patient was normotensive at time of discharge off home Entresto.    Patient was also started on Tamsulosin in the setting of urinary retention with symptoms resolving prior to discharge.    Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of respiratory failure in setting of continued recovery from COVID 19 pneumonia with PCP; follow-up smoking cessation with PCP; consider referral to pulmonology if oxygen requirement persists; follow-up with cardiology regarding chronic heart failure with reduced ejection fraction (Entresto held due to worsening kidney failure and hyperkalemia); follow-up failed right knee prosthesis on suppressive antibiotics with Orthopaedics; follow-up right hand numbness if persists with neurology; follow-up other issues with PCP"
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Viral sepsis
Clinical narrative: Patient with 2 Moderna vaccinations, last dose 05/05/21, who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission:  62 year old male with past medical history significant for nicotine dependence, asthma, obstructive sleep apnea, chronic heart failure with reduced EF in setting of nonischemic dilated cardiomyopathy, status post AICD, left renal infarct due to thromboembolism on chronic anticoagulation, failed right total right knee replacement with removal of prosthesis on suppressive antibiotics, chronic kidney disease stage 2, chronic pain on chronic opiates, anxiety on chronic benzodiazepines and depression presented with acute respiratory failure with hypoxia and viral sepsis in setting of COVID 19 pneumonia.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient required up to 100% FiO2 and 15 liter Venturi mask alternating with non-rebreather. He was started on Decadron while continued on home Eliquis.  Remdesivir was not used in setting of worsening renal failure.   With persistent hypoxia, steroids were escalated to Methylprednisolone 1 mg/kg daily in two divided doses.  Patient's oxygen requirements slowly decreased and oxygen was weaned to 4 liters by nasal cannula by time of discharge.  He was discharged on a prednisone taper.    On admission, patient had worsening renal failure with hyperkalemia.  Patient received a small IV Fluid bolus and home Entresto and loop diuretics were held.  Patient was started on Lokelma three times daily.  Eventually renal function returned towards baseline and patient was started on IV Lasix to promote negative fluid balance and then was transitioned back to his home Torsemide prior to discharge.  Patient was normotensive at time of discharge off home Entresto.    Patient was also started on Tamsulosin in the setting of urinary retention with symptoms resolving prior to discharge.    Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of respiratory failure in setting of continued recovery from COVID 19 pneumonia with PCP; follow-up smoking cessation with PCP; consider referral to pulmonology if oxygen requirement persists; follow-up with cardiology regarding chronic heart failure with reduced ejection fraction (Entresto held due to worsening kidney failure and hyperkalemia); follow-up failed right knee prosthesis on suppressive antibiotics with Orthopaedics; follow-up right hand numbness if persists with neurology; follow-up other issues with PCP"
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Erythema, Extra dose administered, Injection site pruritus, Pruritus
Clinical narrative: I experienced red/rash hive like on my left arm, less on my right, and redness and slight itching of my thighs. The itching feeling of thighs and arms went away after hour; but still see redness (less on thighs). Slight itching at injection site. Dry throat made me paranoid I would have an anaphylactic reaction but I haven't and this is my fourth shot and I have never experienced that. before. This is the first time I have had itching/rash like symptoms after a COVID test - previously just muscle ache, lymph nodes swelling for 24 hours, and extreme fatigue that lasted a day.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Urticaria
Clinical narrative: I experienced red/rash hive like on my left arm, less on my right, and redness and slight itching of my thighs. The itching feeling of thighs and arms went away after hour; but still see redness (less on thighs). Slight itching at injection site. Dry throat made me paranoid I would have an anaphylactic reaction but I haven't and this is my fourth shot and I have never experienced that. before. This is the first time I have had itching/rash like symptoms after a COVID test - previously just muscle ache, lymph nodes swelling for 24 hours, and extreme fatigue that lasted a day.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Injection site pain, Nodule, Pain in extremity, Paraesthesia
Clinical narrative: 4/11/2022 at 1157 Employee called the Employee Health COVID-19 Vaccine Nurse Support Line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date ? 4/08/2022  Booster Dose - Yes Location - Left Deltoid Date of Symptom Onset ? 4/08/2022 Symptoms ? Tingling of Neck and Tongue (During Observation Period and Seen By Nurse); Injection Site Burning, Left Arm Pain, Knot to Left Shoulder Blade Last Day of Work and Shift ? Friday, 4/08/22 / Schedule: Mo-We (11a-8p), Th-Fr (10a-6p) / Missed Work: Monday, 4/11/22 (Came in then had to leave due to symptoms) Home Remedies ? Warm compress to Left Shoulder, Neck and Injection Site; Ibuprofen 800 mg Every 4 Hours Any Improvement ? No Recommendation - Treatment per COVID-19 Vaccine Adverse Reaction Triage and Return to Work Procedure algorithm, is to Manage per Illness in the Workplace Policy  Employee voiced understanding Employee of information ? Yes  Employee voiced any concerns ? No  Employee?s questions answered to employee?s satisfaction - Yes
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: 4/11/2022 at 1157 Employee called the Employee Health COVID-19 Vaccine Nurse Support Line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date ? 4/08/2022  Booster Dose - Yes Location - Left Deltoid Date of Symptom Onset ? 4/08/2022 Symptoms ? Tingling of Neck and Tongue (During Observation Period and Seen By Nurse); Injection Site Burning, Left Arm Pain, Knot to Left Shoulder Blade Last Day of Work and Shift ? Friday, 4/08/22 / Schedule: Mo-We (11a-8p), Th-Fr (10a-6p) / Missed Work: Monday, 4/11/22 (Came in then had to leave due to symptoms) Home Remedies ? Warm compress to Left Shoulder, Neck and Injection Site; Ibuprofen 800 mg Every 4 Hours Any Improvement ? No Recommendation - Treatment per COVID-19 Vaccine Adverse Reaction Triage and Return to Work Procedure algorithm, is to Manage per Illness in the Workplace Policy  Employee voiced understanding Employee of information ? Yes  Employee voiced any concerns ? No  Employee?s questions answered to employee?s satisfaction - Yes
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Burning sensation, Ear swelling, Erythema, Fatigue, Feeling hot
Clinical narrative: 3/21/2022 around 3:20 pm pt noticed redness and swelling in both hands. Both legs were itching and burning. Pt said legs felt like they were on fire. Then she noticed generalized hives all over body including face. She said her neck, face, and both ears were red. Her ears were red, swollen and hot to touch. Pt said she felt tired. She felt like she had fever but did not take her temperature. Denied swelling of lips, tongue, or throat. Denied having any SOB. Took Benadryl around 3:30 pm and all symptoms went away around 4 pm. Pt did not see a doctor for signs or symptoms. Father said they took child to ER but her symptoms were getting better so they did not stay to see the ER doctor. Pt showed me a picture of the hives on her arms and a picture of her neck and face that appeared red and inflamed. Referred pt to see her PCP regarding possible adverse reaction to vaccines. Pt received first set of childhood recommended vaccines on 3/10/2022. Father said child had not received childhood recommended vaccines before due to her brother had an anaphylaxis reaction to vaccines and nearly died. Father plans to take child to see APRN who is child's PCP.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Inflammation, Peripheral swelling, Pruritus, Pyrexia, Urticaria
Clinical narrative: 3/21/2022 around 3:20 pm pt noticed redness and swelling in both hands. Both legs were itching and burning. Pt said legs felt like they were on fire. Then she noticed generalized hives all over body including face. She said her neck, face, and both ears were red. Her ears were red, swollen and hot to touch. Pt said she felt tired. She felt like she had fever but did not take her temperature. Denied swelling of lips, tongue, or throat. Denied having any SOB. Took Benadryl around 3:30 pm and all symptoms went away around 4 pm. Pt did not see a doctor for signs or symptoms. Father said they took child to ER but her symptoms were getting better so they did not stay to see the ER doctor. Pt showed me a picture of the hives on her arms and a picture of her neck and face that appeared red and inflamed. Referred pt to see her PCP regarding possible adverse reaction to vaccines. Pt received first set of childhood recommended vaccines on 3/10/2022. Father said child had not received childhood recommended vaccines before due to her brother had an anaphylaxis reaction to vaccines and nearly died. Father plans to take child to see APRN who is child's PCP.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Blood test, Diarrhoea, Disturbance in attention
Clinical narrative: Extreme digestive upset; constant diarrhea, lethargy, lack of energy and focus, disrupted sleep, brain fog, muscle weakness
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Lethargy, Muscular weakness, Sleep disorder
Clinical narrative: Extreme digestive upset; constant diarrhea, lethargy, lack of energy and focus, disrupted sleep, brain fog, muscle weakness